Literature DB >> 31286231

The pathogenesis of mucositis: updated perspectives and emerging targets.

J Bowen1, N Al-Dasooqi2, P Bossi3, H Wardill2, Y Van Sebille4, A Al-Azri5, E Bateman2, M E Correa6, J Raber-Durlacher7, A Kandwal8, B Mayo4, R G Nair9, A Stringer4, K Ten Bohmer10, D Thorpe4, R V Lalla11, S Sonis12, K Cheng13, S Elad14.   

Abstract

Mucositis research and treatment are a rapidly evolving field providing constant new avenues of research and potential therapies. The MASCC/ISOO Mucositis Study Group regularly assesses available literature relating to pathogenesis, mechanisms, and novel therapeutic approaches and distils this to summary perspectives and recommendations. Reviewers assessed 164 articles published between January 2011 and June 2016 to identify progress made since the last review and highlight new targets for further investigation. Findings were organized into sections including established and emerging mediators of toxicity, potential insights from technological advances in mucositis research, and perspective. Research momentum is accelerating for mucositis pathogenesis, and with this has come utilization of new models and interventions that target specific mechanisms of injury. Technological advances have the potential to revolutionize the field of mucositis research, although focused effort is needed to move rationally targeted interventions to the clinical setting.

Entities:  

Keywords:  Microbiome; Mucositis; Pathogenesis; Permeability; Perspectives; Technology

Mesh:

Year:  2019        PMID: 31286231     DOI: 10.1007/s00520-019-04893-z

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  98 in total

1.  Development of an oral mucosa model to study host-microbiome interactions during wound healing.

Authors:  Tine De Ryck; Charlotte Grootaert; Laura Jaspaert; Frederiek-Maarten Kerckhof; Mireille Van Gele; Joachim De Schrijver; Pieter Van den Abbeele; Simon Swift; Marc Bracke; Tom Van de Wiele; Barbara Vanhoecke
Journal:  Appl Microbiol Biotechnol       Date:  2014-06-11       Impact factor: 4.813

2.  8-prenylnaringenin and tamoxifen inhibit the shedding of irradiated epithelial cells and increase the latency period of radiation-induced oral mucositis : cell culture and murine model.

Authors:  Tine De Ryck; Annouchka Van Impe; Barbara W Vanhoecke; Arne Heyerick; Luc Vakaet; Wilfried De Neve; Doreen Müller; Margret Schmidt; Wolfgang Dörr; Marc E Bracke
Journal:  Strahlenther Onkol       Date:  2014-11-29       Impact factor: 3.621

Review 3.  Modifications of the microflora of the oral cavity arising during immunosuppressive chemotherapy.

Authors:  J L Sixou; O de Medeiros-Batista; M Bonnaure-Mallet
Journal:  Eur J Cancer B Oral Oncol       Date:  1996-09

Review 4.  New thoughts on the pathobiology of regimen-related mucosal injury.

Authors:  Lowell Anthony; Joanne Bowen; Adam Garden; Ian Hewson; Stephen Sonis
Journal:  Support Care Cancer       Date:  2006-04-01       Impact factor: 3.603

Review 5.  Antimicrobial therapy to prevent or treat oral mucositis.

Authors:  J Peter Donnelly; Lisa A Bellm; Joel B Epstein; Stephen T Sonis; R Paul Symonds
Journal:  Lancet Infect Dis       Date:  2003-07       Impact factor: 25.071

Review 6.  Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.

Authors:  Stephen T Sonis; Linda S Elting; Dorothy Keefe; Douglas E Peterson; Mark Schubert; Martin Hauer-Jensen; B Nebiyou Bekele; Judith Raber-Durlacher; J Peter Donnelly; Edward B Rubenstein
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

Review 7.  Emerging evidence on the pathobiology of mucositis.

Authors:  Noor Al-Dasooqi; Stephen T Sonis; Joanne M Bowen; Emma Bateman; Nicole Blijlevens; Rachel J Gibson; Richard M Logan; Raj G Nair; Andrea M Stringer; Roger Yazbeck; Sharon Elad; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2013-04-21       Impact factor: 3.603

8.  5-Fluorouracil sensitivity varies among oral micro-organisms.

Authors:  Eline Vanlancker; Barbara Vanhoecke; Rozel Smet; Ruben Props; Tom Van de Wiele
Journal:  J Med Microbiol       Date:  2016-06-13       Impact factor: 2.472

9.  Oral bacterial community dynamics in paediatric patients with malignancies in relation to chemotherapy-related oral mucositis: a prospective study.

Authors:  Y Ye; G Carlsson; M Barr Agholme; J A L Wilson; A Roos; B Henriques-Normark; L Engstrand; T Modéer; K Pütsep
Journal:  Clin Microbiol Infect       Date:  2013-07-05       Impact factor: 8.067

10.  Gut microbial dysbiosis may predict diarrhea and fatigue in patients undergoing pelvic cancer radiotherapy: a pilot study.

Authors:  Aiping Wang; Zongxin Ling; Zhixiang Yang; Pawel R Kiela; Tao Wang; Cheng Wang; Le Cao; Fang Geng; Mingqiang Shen; Xinze Ran; Yongping Su; Tianmin Cheng; Junping Wang
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

View more
  25 in total

1.  The MASCC/ISOO mucositis guidelines 2019: the second set of articles and future directions.

Authors:  Sharon Elad
Journal:  Support Care Cancer       Date:  2020-05       Impact factor: 3.603

Review 2.  Mitigating acute chemotherapy-associated adverse events in patients with cancer.

Authors:  Nicole M Kuderer; Aakash Desai; Maryam B Lustberg; Gary H Lyman
Journal:  Nat Rev Clin Oncol       Date:  2022-10-11       Impact factor: 65.011

3.  Distinct Nausea Profiles Are Associated With Gastrointestinal Symptoms in Oncology Patients Receiving Chemotherapy.

Authors:  Komal Singh; Keenan Pituch; Qiyun Zhu; Haiwei Gu; Brenda Ernst; Cindy Tofthagen; Melanie Brewer; Kord M Kober; Bruce A Cooper; Steven M Paul; Yvette P Conley; Marilyn Hammer; Jon D Levine; Christine Miaskowski
Journal:  Cancer Nurs       Date:  2022-03-02       Impact factor: 2.760

4.  The progression of doxorubicin-induced intestinal mucositis in rats.

Authors:  F Kullenberg; K Peters; C Luna-Marco; A Salomonsson; M Kopsida; O Degerstedt; M Sjöblom; P M Hellström; F Heindryckx; D Dahlgren; H Lennernäs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-10-22       Impact factor: 3.195

5.  Evaluation of the antiapoptotic and anti-inflammatory properties of chitosan in methotrexate-induced oral mucositis in rats.

Authors:  Kani Bilginaylar; Asli Aykac; Serkan Sayiner; Hanife Özkayalar; Ahmet Özer Şehirli
Journal:  Mol Biol Rep       Date:  2022-01-21       Impact factor: 2.316

Review 6.  A hypothesis for the pathogenesis of radiation-induced oral mucositis: when biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment.

Authors:  Stephen T Sonis
Journal:  Support Care Cancer       Date:  2021-03-13       Impact factor: 3.603

7.  The MASCC/ISOO Mucositis Guidelines 2019 Update: introduction to the first set of articles.

Authors:  Sharon Elad
Journal:  Support Care Cancer       Date:  2019-07-08       Impact factor: 3.359

8.  Dual contribution of the gut microbiome to immunotherapy efficacy and toxicity: supportive care implications and recommendations.

Authors:  Hannah R Wardill; Raymond J Chan; Alexandre Chan; Dorothy Keefe; Samuel P Costello; Nicolas H Hart
Journal:  Support Care Cancer       Date:  2022-03-10       Impact factor: 3.359

Review 9.  Using Bee Products for the Prevention and Treatment of Oral Mucositis Induced by Cancer Treatment.

Authors:  Karsten Münstedt; Heidrun Männle
Journal:  Molecules       Date:  2019-08-21       Impact factor: 4.411

10.  Efficacy and safety of propolis mouthwash in management of radiotherapy induced oral mucositis; A randomized, double blind clinical trial.

Authors:  Farzaneh Dastan; Ahmad Ameri; Samaneh Dodge; Hadi Hamidi Shishvan; Ali Pirsalehi; Mohammad Abbasinazari
Journal:  Rep Pract Oncol Radiother       Date:  2020-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.